Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × abemaciclib × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 11 Neoplasm Metastasis 4 Prostatic Neoplasms 3 Glioma 3 Brain Neoplasms 3 Sarcoma, Ewing 2 Recurrence 2 Neoplasms 2 Meningioma 2 Glioblastoma 2 Endometrial Neoplasms 2 Unilateral Breast Neoplasms 1 Triple Negative Breast Neoplasms 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrent Ovarian High Grade Serous Adenocarcinoma 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasm, Residual 1 Multiple Myeloma 1 Medulloblastoma 1 Malignant Neoplasms of Female Genital Organs 1 Lymphoma, Non-Hodgkin 1 Liver Metastases From Colorectal Cancer (mCRC) 1 Liposarcoma 1 Leiomyosarcoma 1 Hemangiosarcoma 1

Interventions

Specimen Handling 7 Biopsy 6 ruxolitinib 2 fludarabine 2 decitabine and cedazuridine drug combination 2 Azacitidine 2 venetoclax 1 veliparib 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 merphos 1 iadademstat 1 fedratinib 1 axatilimab 1 Topotecan 1 Tacrolimus 1 Succimer 1 Stem Cell Transplantation 1 Pentetic Acid 1 Methotrexate 1 Melphalan 1 Janus Kinase Inhibitors 1 Injections 1 Idarubicin 1 High-Energy Shock Waves 1 Granulocyte Colony-Stimulating Factor 1 Geritol 1 Edetic Acid 1 Decitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡